quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:07:48·70d
SECFiling
Benitec Biopharma Inc. logo

SEC Form 10-Q filed by Benitec Biopharma Inc.

BNTC· Benitec Biopharma Inc.
Health Care
Original source

Companies

  • BNTC
    Benitec Biopharma Inc.
    Health Care

Recent analyst ratings

  • Jul 7UpdateTD Cowen-
  • Dec 16UpdateH.C. Wainwright$28.00
  • Dec 13UpdateRobert W. Baird$30.00
  • Oct 16UpdateOppenheimer$35.00
  • Sep 12UpdateGuggenheim$17.00
  • Jul 22UpdateLeerink Partners$13.00

Related

  • SEC34d
    Amendment: SEC Form 10-K/A filed by Benitec Biopharma Inc.
  • PR44d
    Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for Oculopharyngeal Muscular Dystrophy (OPMD)
  • PR45d
    Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
  • PR59d
    Benitec Biopharma Announces Acceptance of Late- Breaking Abstract for the BB-301 Phase 1b/2a Clinical Treatment Study at the Muscular Dystrophy Association Clinical & Scientific Conference
  • PR70d
    Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
  • SEC70d
    Benitec Biopharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC72d
    SEC Form EFFECT filed by Benitec Biopharma Inc.
  • SEC83d
    SEC Form S-3 filed by Benitec Biopharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022